Hydroxychloroquine in Metastatic Estrogen Receptor-Positive Breast Cancer Progressing on Hormonal Therapy

Summary

To determine the safety and tolerability of orally administered hydroxychloroquine with hormonal therapy. To assess the response rate of hydroxychloroquine in combination with hormonal therapy.

Timeline

Start

2014-07

Primary completion

2015-11

Completion

2015-11

Outcome

Outcome not reported

Stopped: “PI Leaving Site”

Drugs

Indications